PATIENT PREFERENCES FOR TARGETED AGENTS IN RENAL CELL CARCINOMA (RCC): A BENEFIT RISK CONJOINT STUDY
Publication
, Conference
Mohamed, AF; Hauber, B; Johnson, FR; Neary, MP
Published in: ANNALS OF ONCOLOGY
October 1, 2010
Duke Scholars
Published In
ANNALS OF ONCOLOGY
ISSN
0923-7534
Publication Date
October 1, 2010
Volume
21
Start / End Page
292 / 292
Location
Milan, ITALY
Publisher
OXFORD UNIV PRESS
Conference Name
35th European-Society-for-Medical-Oncology (ESMO) Congress
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Mohamed, A. F., Hauber, B., Johnson, F. R., & Neary, M. P. (2010). PATIENT PREFERENCES FOR TARGETED AGENTS IN RENAL CELL CARCINOMA (RCC): A BENEFIT RISK CONJOINT STUDY. In ANNALS OF ONCOLOGY (Vol. 21, pp. 292–292). Milan, ITALY: OXFORD UNIV PRESS.
Mohamed, A. F., B. Hauber, F. R. Johnson, and M. P. Neary. “PATIENT PREFERENCES FOR TARGETED AGENTS IN RENAL CELL CARCINOMA (RCC): A BENEFIT RISK CONJOINT STUDY.” In ANNALS OF ONCOLOGY, 21:292–292. OXFORD UNIV PRESS, 2010.
Mohamed AF, Hauber B, Johnson FR, Neary MP. PATIENT PREFERENCES FOR TARGETED AGENTS IN RENAL CELL CARCINOMA (RCC): A BENEFIT RISK CONJOINT STUDY. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2010. p. 292–292.
Mohamed, A. F., et al. “PATIENT PREFERENCES FOR TARGETED AGENTS IN RENAL CELL CARCINOMA (RCC): A BENEFIT RISK CONJOINT STUDY.” ANNALS OF ONCOLOGY, vol. 21, OXFORD UNIV PRESS, 2010, pp. 292–292.
Mohamed AF, Hauber B, Johnson FR, Neary MP. PATIENT PREFERENCES FOR TARGETED AGENTS IN RENAL CELL CARCINOMA (RCC): A BENEFIT RISK CONJOINT STUDY. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2010. p. 292–292.
Published In
ANNALS OF ONCOLOGY
ISSN
0923-7534
Publication Date
October 1, 2010
Volume
21
Start / End Page
292 / 292
Location
Milan, ITALY
Publisher
OXFORD UNIV PRESS
Conference Name
35th European-Society-for-Medical-Oncology (ESMO) Congress
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis